Ptc therapeutics, inc. (PTCT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Performance obligations satisfied in current period

-

-

-

85,476

-

-

-

68,170

55,981

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues:
Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

897

259

70

-

834

986

1,070

1,152

1,520

Revenue

68,259

96,459

71,416

85,522

53,583

86,338

53,591

68,743

56,062

78,030

41,853

47,962

26,547

25,191

22,986

15,633

18,895

12,734

9,776

6,774

7,482

12,657

1,694

1,677

9,217

4,411

16,289

6,854

7,142

7,195

7,585

Cost of Goods and Service, Excluding Amortization Of Intangible Assets

4,085

3,542

3,006

3,211

2,376

3,761

3,292

2,572

3,045

2,198

1,582

758

39

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Amortization of acquired intangible assets

7,900

8,000

7,000

6,600

6,100

6,072

5,800

5,600

5,428

5,684

9,716

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

90,107

81,831

63,076

59,979

52,566

53,646

54,368

32,607

31,363

29,234

30,024

30,835

27,363

26,011

31,396

28,827

31,399

35,048

30,640

28,190

27,938

26,871

18,765

18,313

15,889

15,020

13,886

14,712

11,257

10,466

11,918

Selling, general and administrative

58,209

63,498

49,284

49,215

40,544

48,666

38,368

33,545

32,969

35,482

31,423

28,866

25,500

24,172

23,654

23,366

25,938

25,887

21,368

17,210

17,615

18,017

10,530

8,733

7,540

7,484

6,679

6,595

4,461

3,783

3,164

Change in the fair value of deferred and contingent consideration

-900

-12,400

-9,500

-5,300

-21,160

-19,340

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

161,250

169,244

131,891

124,280

122,723

131,476

101,821

74,317

72,805

72,578

72,745

60,459

52,902

50,183

55,050

52,193

57,337

60,935

52,008

45,400

45,553

44,888

29,295

27,046

23,429

22,504

20,565

21,307

15,718

14,250

15,083

Loss from operations

-92,991

-72,785

-60,475

-38,758

-69,140

-45,138

-48,230

-5,574

-16,743

5,452

-30,892

-12,497

-26,355

-24,992

-32,064

-36,560

-38,442

-48,201

-42,232

-38,626

-38,071

-32,231

-27,601

-25,369

-14,212

-18,093

-4,276

-14,453

-8,576

-7,055

-7,498

Interest expense, net

-5,642

-5,463

-2,666

-2,074

-2,288

-3,249

-3,118

-2,884

-3,303

-3,446

-3,421

-3,008

-2,219

-2,127

-2,133

-2,060

-1,956

-2,537

-852

498

524

407

354

248

171

165

27

-114

-6,162

-247

-335

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-130

-

-

-

-

Other expense, net

-13,832

11,215

2,800

-183

-109

-936

734

-673

1,004

93

766

-1,820

-318

687

-786

-387

-721

42

-51

-88

-368

-138

-35

17

-57

40

-37

-19

54

5

1,765

Loss before income tax expense

-112,465

-67,033

-60,341

-41,015

-71,537

-49,323

-50,614

-9,131

-19,042

2,099

-33,547

-17,325

-28,892

-26,432

-34,983

-39,007

-41,119

-50,696

-43,135

-38,216

-37,915

-

-27,282

-25,104

-

-

-

-

-

-

-

Income tax expense

222

10,644

-344

774

576

-994

355

389

221

829

191

150

165

364

184

-93

114

-

88

145

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-112,687

-77,677

-59,997

-41,789

-72,113

-48,329

-50,969

-9,520

-19,263

1,270

-33,738

-17,475

-29,057

-

-

-

-

-

-

-

-

-

-27,282

-25,104

-14,098

-17,888

-4,416

-14,586

-14,684

-7,297

-6,068

Deemed dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

18,249

-

-

Gain on exchange of convertible preferred stock in connection with recapitalization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,391

-

159,954

Less beneficial conversion charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

377

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35,167

-38,914

-41,233

-

-43,223

-38,361

-37,915

-

-

-

-

-17,888

-4,416

-14,586

-29,542

-7,297

153,508

Basic net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,605.53

-

Diluted net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,605.53

-

Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted

62,389

67,221

56,463

55,912

55,855

50,444

48,096

46,137

41,626

41,507

41,296

39,621

34,305

34,170

34,088

34,000

33,919

33,927

33,908

33,600

33,067

43,084

29,351

29,332

24,492

24,861

23,803

2,648

4

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

3

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

10

Earnings Per Share [Abstract]
Earnings Per Share, Basic and Diluted

-1.81

-1.17

-1.06

-0.75

-1.29

-1.02

-1.06

-0.21

-0.46

0.09

-0.82

-0.44

-0.85

-0.78

-1.03

-1.14

-1.22

-1.51

-1.27

-1.14

-1.15

-0.60

-0.93

-0.86

-0.58

6,527.82

-0.19

-5.51

-6,527.30

-

-

Net income (loss) per share applicable to common stockholders-basic (unaudited)(in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

168.00

Net income (loss) per share applicable to common stockholders-diluted (unaudited)(in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48.29

Product [Member]
Revenue

68,196

81,407

71,369

85,476

53,054

85,833

53,021

68,170

55,981

-

-

-

26,442

25,119

22,013

15,437

18,878

12,694

9,772

6,161

5,069

-

81

-

-

-

-

-

-

-

-

Collaboration and grant revenue
Revenue

63

15,052

47

46

529

-

570

573

-

-

-

-

105

72

973

196

17

40

4

613

2,413

13,247

716

1,418

9,147

7,301

15,455

5,868

6,072

6,042

6,064